Nunn E, Jaiswal N, Gavin M, et al
Experience fewer cravings, more balance, and a healthier relationship with food all in one simple daily capsule
Front Immunol (2020) 11:610363
14.2 Weight Management Trial in Pediatric Patients Ages 12 and Older with Obesity SAXENDA was evaluated in a 56-week, double-blind, randomized, parallel group, placebo controlled multi-center trial in 251 pubertal pediatric patients aged 12 to 17 years, with BMI corresponding to 30 kg/m2 or greater for adults by international cut-off points1 and BMI of 95th percentile or greater for age and sex (NCT02918279)
GLP-1 medications are generally avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, a history of pancreatitis, severe gastroparesis or active gastrointestinal motility disease, pregnancy or plans to become pregnant, or an active eating disorder
Retatrutide may face similar challenges